Blue Cross Blue Shield of North Dakota (BCBSND) continually develops and revises pharmacy policies in response to rapidly changing pharmaceutical requirements. Our commitment is to update the provider community as pharmacy policies are adopted and/or revised.
Commercial Updates - Medical Pharmacy
The following Commercial prior authorization medical drug policies are new and effective Nov. 1, 2026:
*see www.gatewaypa.com/policydisplay/52 on or after Nov. 1, 2026
- Bendamustine-Avyxa
- Lytenava (bevacizumab-vikg)
- Ponlimsi (denosumab-adet)
- Tudriqev (vusolimogene oderparepvec-wtpg)
